Shockwave Medical (NASDAQ:SWAV) Given Hold Rating at Needham & Company LLC

Shockwave Medical (NASDAQ:SWAV – Get Free Report)‘s stock had its “hold” rating reissued by equities researchers at Needham & Company LLC in a report released on Friday, Benzinga reports. A number of other equities analysts have also weighed in on SWAV. Wells Fargo & Company increased their target price on shares of Shockwave Medical from […]

Leave a Reply

Your email address will not be published.

Previous post Wolfe Research Reaffirms Peer Perform Rating for Shockwave Medical (NASDAQ:SWAV)
Next post The Goldman Sachs Group Raises Primoris Services (NASDAQ:PRIM) Price Target to $43.00